Dilated cardiomyopathy: An unusual and severe condition in juvenile systemic lupus erythematosus

Kenza Bouayed1, Tiaaza Faid1, Asmaa Sakhi1

  • 1Department of Pediatric Rheumatology and Internal Medicine, A. Harouchi Mother-Child Hospital, Ibn Rochd University Hospital, 92957Hassan II University, Casablanca, Morocco.

Lupus
|March 21, 2022
PubMed

Insights

Systemic juvenile lupus erythematosus can cause rare dilated cardiomyopathy. This case shows full recovery with timely treatment and monitoring, highlighting the importance of cardiac evaluation.

Area of Science:

  • Pediatric Rheumatology
  • Cardiology

Background:

  • Systemic juvenile lupus erythematosus (sJLE) can manifest with cardiac involvement, though dilated cardiomyopathy is an uncommon complication.
  • While pericarditis and endocarditis are more frequent, this report focuses on a rare instance of dilated cardiomyopathy in a child with sJLE.

Observation:

  • A 7-year-old girl presented with constitutional symptoms, alopecia, and serological markers of lupus.
  • Clinical examination revealed signs of heart failure, including dyspnea, tachycardia, and hypotension, with imaging confirming significantly reduced left ventricular ejection fraction.

Findings:

  • The patient was diagnosed with systemic lupus erythematosus-related dilated cardiomyopathy and treated with standard heart failure therapy, corticosteroids, and hydroxychloroquine.
  • She experienced a concurrent episode of macrophage activation syndrome, which was successfully managed with methylprednisolone.

Implications:

  • Complete recovery of cardiac function was observed within four months of treatment initiation.
  • This case underscores the critical need for echocardiography in children with juvenile lupus presenting with any cardiac symptoms, given the potential for severe but reversible cardiomyopathy.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
46
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
64
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
76
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
69
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
94